DMII · Drugs Made In America Acquisition II Corp.
$10.11
+0.00 (+0.00%)
At close · Aug 5
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“In connection with our assessment of going concern considerations in accordance with Financial Accounting Standard Board's Accounting Standards Update ("ASU") 2014-15, "Disclosures of Uncertainties about an Entity's Ability to Continue as a Going Concern," management has determined that these conditions raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that the financial statements are issued.”View the 10-Q filed May 14, 2026
Market Cap
$644.01M
Shares
63.70M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-07-09 | 6 | $10.11 | $61 |
| 2026-07-07 | 5,000 | $10.09 | $50,450 |
| 2026-06-30 | 1,171 | $10.07 | $11,792 |
| 2026-06-22 | 1 | $10.10 | $10 |
| 2026-06-18 | 1 | $10.09 | $10 |
| 2026-05-26 | 5,334 | $10.06 | $53,660 |
| 2026-05-22 | 5,343 | $10.04 | $53,644 |
| 2026-05-21 | 2,189 | $10.05 | $21,999 |
| 2026-05-14 | 8,962 | $10.03 | $89,889 |
| 2026-05-13 | 25 | $10.03 | $251 |
| 2026-05-12 | 25 | $10.03 | $251 |
| 2026-05-08 | 2,534 | $10.02 | $25,391 |
| 2026-05-07 | 408 | $10.01 | $4,084 |
Showing 1–13 of 13 settlements
Key facts
CIK
2040475
CUSIP
G2851K104
13F (30d)
8 filings
8 filers